These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8374912)

  • 1. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation.
    Baumeister AA; Todd ME; Sevin JA
    Clin Neuropharmacol; 1993 Aug; 16(4):271-94. PubMed ID: 8374912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of pharmacological agents for self-injurious behavior.
    Luchins DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S169-79. PubMed ID: 2097670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology and mental retardation: a 10 year review (1990-1999).
    Matson JL; Bamburg JW; Mayville EA; Pinkston J; Bielecki J; Kuhn D; Smalls Y; Logan JR
    Res Dev Disabil; 2000; 21(4):263-96. PubMed ID: 10983783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.
    Schroeder SR; Rojahn J; Reese RM
    J Autism Dev Disord; 1997 Feb; 27(1):89-102. PubMed ID: 9018584
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting of medication regimen in applied studies of persons with mental retardation and ADHD.
    Christian L; Kerr CL; Sutphin GE; Poling A
    Res Dev Disabil; 1997; 18(5):319-27. PubMed ID: 9292927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication regimen: a subject characteristic rarely reported in behavior modification studies.
    Poling A; Grossett D; Karas CA; Breuning SE
    Appl Res Ment Retard; 1985; 6(1):71-7. PubMed ID: 2859837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
    van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: clonazepam behavioral side effects with an individual with mental retardation.
    Kalachnik JE; Hanzel TE; Sevenich R; Harder SR
    J Autism Dev Disord; 2003 Jun; 33(3):349-54. PubMed ID: 12908837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects and long-term efficacy of antidepressant medication for persons with developmental disabilities. Behavioral assessment in two cases of treatment-resistant aggression and self-injury.
    Luiselli JK; Blew P; Thibadeau S
    Behav Modif; 2001 Jan; 25(1):62-78. PubMed ID: 11151486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of recent drug research in mental retardation: the Coldwater studies.
    Aman MG; Singh NN
    J Ment Defic Res; 1986 Sep; 30 ( Pt 3)():203-16. PubMed ID: 2878082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic-based pharmacological treatment of behavior disorders in persons with developmental disabilities: a review and a decision-making typology.
    Sturmey P
    Res Dev Disabil; 1995; 16(4):235-52. PubMed ID: 7480954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating behavioral and pharmacological interventions in treating clients with psychiatric disorders and mental retardation.
    Sevin JA; Bowers-Stephens C; Hamilton ML; Ford A
    Res Dev Disabil; 2001; 22(6):463-85. PubMed ID: 11768671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities.
    Aman MG
    Ann Clin Psychiatry; 1993 Sep; 5(3):171-88. PubMed ID: 7904217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonneuroleptic treatment of disruptive behavior in organic mental syndromes.
    Smith DA; Perry PJ
    Ann Pharmacother; 1992 Nov; 26(11):1400-8. PubMed ID: 1362095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.